What We're Reading: Page 10
Industry reads hand-picked by our editors
Feb 24, 2026
Feb 23, 2026
Feb 20, 2026
-
Axios
Big Pharma financially unfazed by White House drug price deals
-
Bloomberg
Pfizer Ponders Viagra Lessons to Chart First Obesity Drug Launch
-
The Washington Post
After leaving WHO, Trump officials propose more expensive replacement to duplicate it
-
Quanta Magazine
The Biophysical World Inside a Jam-Packed Cell
Feb 19, 2026
Feb 18, 2026
-
Stat
At drugmakers’ forum, Oz gets a friendly embrace, while Makary faces tough questions
-
AP News
Bayer strikes $7.25 billion deal to settle Roundup cancer lawsuits
-
Reuters
Lilly targets India as global export hub amid booming Mounjaro sales, executive says
-
The New York Times
A New Concern About Weight Loss Drugs: What if They Work Too Well?
Feb 17, 2026
-
The Wall Street Journal
How Ozempic Brought a Napster Moment to Big Pharma
-
Reuters
Sectors Up Close: Biotech investment during COVID ‘paying off’
-
MIT Technology Review
The scientist using AI to hunt for antibiotics just about everywhere
-
The Atlantic
This Is How a Child Dies of Measles
Feb 13, 2026
-
Reuters
China biotech licensing boom to hit record in 2026 as pipeline swells
-
Quanta Magazine
Fed on Reams of Cell Data, AI Maps New Neighborhoods in the Brain
-
The New York Times
Health Advice From A.I. Chatbots Is Frequently Wrong, Study Shows
-
National Geographic
These drugs could be a game changer for end-of-life care